Clinical and pathologic features of secondary acute promyelocytic leukemia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Clinical Pathology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1309/AJCPE0MV0YTWLUUEPMID 22338051PMCID PMC3578661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome

  2011cited by this paper
• Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.

  2011cited by this paper
• Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis

  2011cited by this paper
• Therapy-related acute promyelocytic leukemia

  2011cited by this paper
• Unusual acute promyelocytic leukemia following de novo renal transplant: case report and literature review.

  2011cited by this paper
• The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.

  2011cited by this paper
• Unusual acute promyelocytic leukemia following de novo renal transplant: case report and literature review.

  2011cited by this paper
• Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review.

  2010cited by this paper
• Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients

  2010cited by this paper
• Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia

  2009cited by this paper
• Therapy-related myeloid neoplasms

  2009cited by this paper
• Therapy-related myeloid neoplasms.

  2009cited by this paper
• Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required

  2009cited by this paper
• Therapy-related myeloid leukemia.

  2008cited by this paper
• Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.

  2008cited by this paper
• WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2007cited by this paper
• Therapy-related acute myelogenous leukemia and myelodysplastic syndrome

  2007cited by this paper
• The value of autofluorescence as a diagnostic feature of acute promyelocytic leukemia.

  2006cited by this paper
• Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

  2005cited by this paper
• Chromosomal Translocation t ( l 5 ; 17 ) in Human Acute Promyelocytic Leukemia Fuses RARa with a Novel Putative Transcription Factor , PML

  2003cited by this paper
• Therapy-related acute promyelocytic leukemia.

  2003cited by this paper
• Internal tandem duplication and Asp835 mutations of the FMS‐like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia

  2003cited by this paper
• Balanced chromosome abnormalities inv(16) and t(15;17) in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop †

  2002cited by this paper
• Unique balanced chromosome abnormalities in treatment‐related myelodysplastic syndromes and acute myeloid leukemia: Report from an International Workshop †

  2002cited by this paper
• Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001

  2002cited by this paper
• The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?

  2000cited by this paper
• Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

  2000cited by this paper
• CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy.

  2000cited by this paper
• Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.

  1996cited by this paper
• All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

  1995cited by this paper
• Therapy-related acute promyelocytic leukemia: a report on 16 cases.

  1992cited by this paper

• An Update on Flow Cytometry Analysis of Hematological Malignancies: Focus on Standardization

  2025cites this paper
• Full spectrum flow cytometry in the clinical laboratory

  2023cites this paper
• Therapy-Related Acute Promyelocytic Leukemia Developed During Pembrolizumab Therapy

  2023cites this paper
• Optimizing outcomes in secondary AML.

  2022cites this paper
• Differential Survival Outcomes Between De Novo and Secondary Acute Promyelocytic Leukemia: An Updated Population-based study.

  2021cites this paper
• Secondary AML

  2021cites this paper
• Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient

  2020cites this paper
• Therapy-related acute promyelocytic leukemia with FMS-like tyrosine kinase 3-internal tandem duplication mutation in solitary bone plasmacytoma: A case report

  2020cites this paper
• Characterization of secondary and therapy-related acute myeloid leukemia

  2020cites this paper
• Therapy-related myeloid neoplasms: clinical perspectives

  2018cites this paper
• Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014

  2018cites this paper
• Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases

  2018cites this paper
• Therapy-Related Acute Promyelocytic Leukemia

  2018cites this paper
• Anticancer therapy - related acute myeloid leukemias

  2017cites this paper
• Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

  2017cites this paper
• Chromosomal abnormality of acute promyelocytic leukemia other than PML-RARA: a case report of acute promyelocytic leukemia with del(5q)

  2016cites this paper
• Acute Promyelocytic Leukemia After Renal Transplant and Filgrastim Treatment for Neutropenia

  2016cites this paper
• CD34(+) therapy-related acute promyelocytic leukemia in a patient previously treated for breast cancer.

  2016cites this paper
• Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database

  2016cites this paper
• An Unusual Case of Acute Promyelocytic Leukemia Presenting With Hypoplastic Bone Marrow and Pancytopenia.

  2016cites this paper
• Sequential development of two separate therapy-related myeloid neoplasms following radiotherapy for prostate cancer

  2016cites this paper
• Acute Promyelocytic Leukemia: a Single Center Study from Southern Pakistan.

  2015cites this paper
• Exploring the anti-leukemic effect of the combination treatment with Valproic acid, Lonidamine and Mycophenolate mofetil in acute myeloid leukemia

  2015cites this paper
• Global characteristics of childhood acute promyelocytic leukemia.

  2015cites this paper
• Therapy-related acute promyelocytic leukemia after chemoradiotherapy with capecitabine for rectal adenocarcinoma

  2014cites this paper
• Acute promyelocytic leukemia: what is the new standard of care?

  2014cites this paper
• Zależna od terapii ostra białaczka szpikowa — czynniki ryzyka i leczenie Therapy-related acute myeloid leukemia — the risk factors and treatment

  2014cites this paper
• Treatment related myeloid malignancies in childhood

  2014cites this paper
• Acute myeloid leukemia: advances in diagnosis and classification

  2013cites this paper
• Evaluation of prognostic factors in patients with therapy-related acute myeloid leukemia

  2013cites this paper
• Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.

  2013cites this paper
• Biology and management of therapy-related acute promyelocytic leukemia

  2013cites this paper
• Therapy-Related Acute Myelogenous Leukemia

  2013cites this paper
• Therapy-related acute promyelocytic leukemia: a systematic review

  2013influential citation
• Therapy-Related Acute Myeloid Leukemias

  2013cites this paper
• Therapy-related acute myeloid leukemia with favorable cytogenetics: still favorable?

  2012cites this paper
• CD34(+) Therapy-Related Acute Promyelocytic Leukemia in a CD34(+) Therapy-Related Acute Promyelocytic Leukemia in a Patient Previously Treated for Breast Cancer Patient Previously Treated for Breast Cancer

  year unknowncites this paper